Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Denardo

Showing results (241-250 of 274) with videos related to

Pageof 28
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|July 27, 2001
Apoptosis-related gene and protein expression in human lymphoma xenografts (Raji) after low dose rate radiation using 67Cu-2IT-BAT-Lym-1 radioimmunotherapyL A Kroger, G L DeNardo, P H Gumerlock, et al.
The International Journal of Biological Markers|October 1, 1991
Radioimmunotherapy for breast cancer: treatment of a patient with I-131 L6 chimeric monoclonal antibodyS J DeNardo, K A Warhoe, L F O'Grady, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1993
Radioimmunolocalization of metastatic breast carcinoma using indium-111-methyl benzyl DTPA BrE-3 monoclonal antibody: phase I studyE L Kramer, S J DeNardo, L Liebes, et al.
Anticancer Research|May 1, 1997
Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancerS J Denardo, C M Richman, D S Goldstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1997
Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: efficacy and toxicity in breast cancer xenograftsS J DeNardo, D L Kukis, L A Kroger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1986
Multicompartmental analysis of the kinetics of radioiodinated monoclonal antibody in patients with cancerK Koizumi, G L DeNardo, S J DeNardo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1996
Prediction of radiation doses from therapy using tracer studies with iodine-131-labeled antibodiesD A DeNardo, G L DeNardo, A Yuan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1997
Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: results of a phase I clinical trialS J DeNardo, E L Kramer, R T O'Donnell, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Radioimmunotherapy of acquired immunodeficiency syndrome (AIDS) associated lymphomaR T O'Donnell, B R Leigh, S D Christensen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 5, 2000
A clinical trial of radioimmunotherapy with 67Cu-2IT-BAT-Lym-1 for non-Hodgkin's lymphomaR T O'Donnell, G L DeNardo, D L Kukis, et al.
Pageof 28

Showing results (241-250 of 274) with videos related to

Sort By:
Pageof 28
Cancer Biotherapy & Radiopharmaceuticals|July 27, 2001
Apoptosis-related gene and protein expression in human lymphoma xenografts (Raji) after low dose rate radiation using 67Cu-2IT-BAT-Lym-1 radioimmunotherapyL A Kroger, G L DeNardo, P H Gumerlock, et al.
The International Journal of Biological Markers|October 1, 1991
Radioimmunotherapy for breast cancer: treatment of a patient with I-131 L6 chimeric monoclonal antibodyS J DeNardo, K A Warhoe, L F O'Grady, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1993
Radioimmunolocalization of metastatic breast carcinoma using indium-111-methyl benzyl DTPA BrE-3 monoclonal antibody: phase I studyE L Kramer, S J DeNardo, L Liebes, et al.
Anticancer Research|May 1, 1997
Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancerS J Denardo, C M Richman, D S Goldstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1997
Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: efficacy and toxicity in breast cancer xenograftsS J DeNardo, D L Kukis, L A Kroger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1986
Multicompartmental analysis of the kinetics of radioiodinated monoclonal antibody in patients with cancerK Koizumi, G L DeNardo, S J DeNardo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1996
Prediction of radiation doses from therapy using tracer studies with iodine-131-labeled antibodiesD A DeNardo, G L DeNardo, A Yuan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1997
Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: results of a phase I clinical trialS J DeNardo, E L Kramer, R T O'Donnell, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Radioimmunotherapy of acquired immunodeficiency syndrome (AIDS) associated lymphomaR T O'Donnell, B R Leigh, S D Christensen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 5, 2000
A clinical trial of radioimmunotherapy with 67Cu-2IT-BAT-Lym-1 for non-Hodgkin's lymphomaR T O'Donnell, G L DeNardo, D L Kukis, et al.
Pageof 28